ArticleCancer immunology, immunotherapy : CII2007

Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis.

Kai-Da Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.